![Michael Bolinder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Michael Bolinder worked at Mallinckrodt Pharmaceuticals Ltd. from 2013 to 2015 as Head-Marketing & Commercial Strategy.
From 2015 to 2022, Mr. Bolinder was at Acacia Pharma Group Ltd., serving as Chief Executive Officer from 2019 to 2022.
Mr. Bolinder completed undergraduate education at Florida State University.
Anciens postes connus de Michael Bolinder
| Sociétés | Poste | Fin |
|---|---|---|
| ACACIA PHARMA GROUP PLC | Directeur Général | 01/06/2022 |
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Sales & Marketing | 01/08/2015 |
Formation de Michael Bolinder
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
7
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Florida State University
 Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acacia Pharma Group Ltd.
 Acacia Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that engages in developing and commercializing novel products for surgery, invasive procedures & chemotherapy | Health Technology |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Choisissez Zonebourse 
